American Journal of Hematology Issues Research Articles in June 2024 Edition
May 27, 2024
May 27, 2024
HOBOKEN, New Jersey, May 27 -- The American Journal of Hematology, a journal that says it provides coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease, published research articles on the following topics in its June 2024 edition (Vol. 99, Issue 6):
COMMENTARIES:
* Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?
* Let's get "real" in . . .
COMMENTARIES:
* Crizanlizumab and sickle cell disease: When should medications have their approval status revoked?
* Let's get "real" in . . .